Valeant Pharmaceuticals International Inc., of Laval, Quebec, said it filed a preliminary proxy statement for a special shareholders meeting, at which Valeant shareholders will consider and vote upon, among other issues, a proposal to approve the issuance of Valeant common shares in connection with an acquisition of Allergan Inc., of Irvine, Calif.